Human respiratory syncytial virus (HRSV) is the leading viral cause of severe respiratory 2 illness in infants and young children worldwide. Two major antigenic groups (A and B) of 3 HRSV exist and viruses from both subgroups can cocirculate during epidemics, however their 4 frequencies might vary between seasons. The subgroup prevalence and genotype distribution 5 patterns of HRSV strains were investigated in a community in Belgium during 10 successive 6 epidemic seasons (1996)(1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006). A regular 3-yearly cyclic pattern of subgroup dominance was 7 observed, consisting of two predominant HRSV-A seasons, followed by a single HRSV-B 8 dominant year. HRSV infections with both subgroups were more prevalent in children 9 younger that 6 months of age and had a peak incidence in December. The most frequently 10 detected genotypes were GA5 and GB13, the latter including strains with the 60-nt 11 duplication in the G gene. Furthermore, GA5 remained the dominant HRSV genotype in two 12 subsequent epidemic seasons, observed twice during the study period. Additional variability 13 was detected among the GB13 isolates, due to the usage of a novel termination codon in the G 14 gene. Dual infections with both HRSV subgroups were detected in 9 patients and repeated 15 infections with the heterologous HRSV subgroup were documented in 15 patients. Among 16 five patients with homologous reinfections, only one was caused by HRSV-B viruses. Our 17 results support the hypothesis that the overall prevalence of HRSV-A over HRSV-B viruses 18 could be due to a more transient subgroup A specific immune protection. 19
INTRODUCTION 1
Human respiratory syncytial virus (HRSV) is the leading viral cause of pneumonia and 2 bronchiolitis in infants and young children worldwide (4, 8, 16) . It is also recognized as an 3 important respiratory pathogen in the elderly, individuals with cardiopulmonary disease, and 4 the immunocompromised (9). By the age of 2 years, virtually all infants would have 5 experienced at least one HRSV infection. Reinfections are very common throughout life and 6 in older children and adults they are usually associated with milder disease, indicating that 7 HRSV infections induce only partial immunity (14, 19) . 8
HRSV is an enveloped virus with a non-segmented, negative-stranded RNA genome and 9 is classified in the family Paramyxoviridae (8). Two major subgroups, A (HRSV-A) and B 10 (HRSV-B), have been initially identified based on distinct reactivity patterns with panels of 11 monoclonal antibodies (2, 27) . Subsequent sequencing data revealed that these antigenic 12 groups correspond to genetically distinct viruses. The most extensive antigenic and genetic 13 differences between and within the two subgroups are found in the attachment G glycoprotein 14 (4, 21, 38) . The G attachment protein is also one of the main targets for inducing neutralizing 15 and protective antibodies (29) and it has been suggested that antigenic differences within this 16 protein could facilitate HRSV to cause repeated infections (21) . 17
Epidemiological surveys have revealed that strains from both HRSV subgroups can be 18 present in the same community during outbreaks, however their relative proportions may vary 19 between epidemics (3, 4, 10, 20) . HRSV has complex circulation patterns with multiple 20 genotypes or lineages cocirculating within the same community and replacement of the 21 predominating genotypes with new ones over successive epidemic seasons (1, 5, 6, 13, 18, 22 33) . HRSV genotype distribution patterns can be distinctive for each community, and it has 23 been suggested to be determined by local factors such as the level of herd immunity to certain 24 strains (1, 5, 32) . 25
A C C E P T E D RESULTS

1
HRSV typing and subgroup prevalence. Twenty samples that were reactive in the 2 antigen assay were identified to be negative for HRSV RNA by using the RT-PCR and qRT-3 PCR assays. These samples were considered to be HRSV antigen false positives and were 4 therefore excluded from further analysis, resulting in a total number of 1392 HRSV antigen 5 positive samples. HRSV strains were characterized as subgroup A or B in 979 (70%) of the 6 samples, of which 608 (62%) were subtyped by multiplex RT-PCR, 166 (17%) by multiplex 7
qRT-PCR and 205 (21%) strains were previously subtyped by RT-PCR and sequencing 8 analyses as described elsewhere (48, 49). As a result, 537 (55%) belonged to subgroup A, 433 9 (44%) to subgroup B and in 9 (1%) specimens both HRSV-A and -B viruses were identified. 10
The proportion of typed HRSV antigen positive samples from each epidemic season varied 11 between 59% and 83% ( Table 2 ). The majority of the typed HRSV strains were obtained 12 directly from the clinical samples. Due to the lack of sufficient sample material and absence 13 of the respective cell cultured virus strain, we were not able to analyze all HRSV antigen 14 positive samples. 15 HRSV-A and -B strains cocirculated during all 10 epidemic seasons. Subgroup A viruses 16 were predominant during 7 epidemic seasons, while subgroup B strains prevailed during the 17 epidemic seasons 1998/1999, 2001/2002, and 2004/2005 . A regular pattern of subgroup 18 predominance replacement was observed, consisting of two consecutive seasons of HRSV-A 19 dominance followed by a single intervening season of HRSV-B dominance. 20
Monthly and age distribution of HRSV infections. HRSV outbreak activity in Belgium 21
was high during the months November, December and January and had a peak incidence in 22 December (Fig. 1) . HRSV strains from both subgroups were isolated with a higher frequency 23 during the peak outbreak months. Sixteen sporadic HRSV infections were observed during 24 the period from May to September. The distribution of HRSV-A and -B infections wassimilar for the four age groups defined in this study. HRSV infections with both subgroups 1 were significantly more frequent (P<0.05) in children younger than 6 months of age (Fig. 2) . 2 Phylogenetic analyses and genotype distribution patterns. Phylogenetic analyses were 3 conducted on a total number of 119 HRSV-A and 163 HRSV-B Belgian G-gene sequences, 4 which included also the 56 HRSV-A and 21 HRSV-B additionally sequenced strains (48, 49) 5 (Fig. 3A and 3B ). Two major HRSV-A genotypes (GA2 and GA5) and 8 HRSV-B genotypes 6 (GB2, GB3, GB6, GB8, GB10-GB13) were detected among the Belgian HRSV strains during 7 the 10-year study period. Multiple identical sequences were identified and the majority was 8 from strains isolated during the same epidemic season. Exceptions from the latter observation 9 included 3 HRSV-A strains that had identical sequences to strains that were circulating 5 to 7 10 epidemic seasons earlier and 8 HRSV-B strains had identical sequences to strains obtained 11 before 1 to 3 epidemic seasons. The HRSV-A and -B genotype distribution during each 12 epidemic season is shown in Table 3 . Two to 7 genotypes were identified in a single outbreak 13 and the dominant HRSV genotype shifted in every 1 to 2 following seasons. HRSV-A 14 genotypes tended to prevail for 1 or 3 successive epidemics, whereas HRSV-B genotypes 15 predominated for 1 to 4 consecutive seasons. GA5 was the prevailing subgroup A genotype 16 during 7 epidemics and was the only HRSV genotype to dominate in subsequent seasons 17 (1999/2000, 2000/2001 and 2002/2003, 2003/2004 frequently isolated HRSV-B genotypes were GB12 and GB13, which were observed in 7 and 22 6 epidemic seasons, respectively and were also the prevailing subgroup B genotype 23 respectively in 5 and 4 outbreaks. GB13, which included strains with the 60-nt duplication, 24 was the dominant HRSV genotype during the two subgroup B prevalent outbreaks 25 A C C E P T E D 1 last three seasons (2003/2004, 2004/2005, 2005/2006) . In addition to the five different 2 predicted protein lengths (282, 312, 315, 317 , and 319 aa) that we have previously reported 3 among GB13 Belgian strains (48) (Table 4) . One patient had an initial dual infection with both HRSV subgroups and 24 was reinfected with a subgroup A strain after 11 months. More than two infections were 25
A C C E P T E D
detected in the two asthmatic patients. One of them had four HRSV infections over a period 1 of 5 years. The first infection (not typed) was encountered at the age of 4 months; the second 2 infection was after 13 months and was caused by HRSV-B, followed by two more infections 3 caused by HRSV-A, encountered respectively after 24 and 60 months. The G-gene sequences 4 of the two HRSV-A strains (BE/14807/98-99 and BE/14616/03-04) from this patient 5 clustered within genotype GA5 and differed in 16 (2.5%) nucleotide positions resulting in 6 6 (3%) differences on the deduced amino acid level. The second asthmatic child experienced 7 three infections during three subsequent epidemic seasons, the initial infection was not typed 8 and the following two infections were caused by HRSV-A. The homologous HRSV-B 9 infections identified in one patient occurred 70 months apart and were caused by a GB12 10 (BE/1054/97-98) and a GB13 strain with the 60-nt duplication and 6-nt deletion 11 (BE/12963/03-04). The number of genetic differences, identified between the two subgroup B 12 strains was 83 (11%) on the nucleotide level and 30 (12%) on the deduced amino acid level. 13 DISCUSSION 1 HRSV viruses from both subgroups were cocirculating in each of the 10 epidemic 2 seasons investigated in Belgium, however HRSV-A strains were isolated more frequently and 3 were predominant during 7 seasons. The monthly distribution of HRSV-A and -B infections 4 was similar, with a high prevalence during the winter months November to January and a 5 peak incidence in December. These findings indicate that viruses from both subgroups have 6 similar temporal occurrence. The occasional isolation of HRSV in May to September suggests 7 that the virus is present in the community continuously throughout the year. HRSV is highly 8 transmissible and is spread via respiratory secretions by close contact with infected 9 individuals, or indirectly through exposure to contaminated surfaces (17). Thus, the very low 10 incidence of HRSV infections during the summer months is probably due to less indoor 11 crowding, which can limit further spread of the virus. Infections with both subgroups were 12 more prevalent in children younger than 6 months of age. 13
A more frequent detection of HRSV-A viruses during outbreaks has been observed 14 worldwide (4, 12, 26, 31) . In a community a shift in the HRSV subgroup dominance can 15 occur at different time intervals and different patterns of subgroup A and B prevalence have 16 been described. In Finland the HRSV subgroup dominance changed every two years during 17 10 consecutive years (46), while in Rochester, NY a cyclic pattern, consisting of 1 to 2 18 consecutive years of high subgroup A dominance followed by a single intervening year of 19 subgroup B dominance or by co-dominance of both subgroups was observed during a 15-year 20 period (18). Similar subgroup occurrence has been seen in Kenya, Uruguay and the United 21
States, where HRSV-B became predominant after two subsequent seasons of high subgroup A 22 prevalence (3, 7, 37) . During the 10 successive epidemic seasons investigated in Belgium, a 23 regular 3-yearly cyclic pattern of subgroup occurrence was observed. It consisted of two 24 consecutive HRSV-A predominant seasons, followed by a single HRSV-B predominantseason. Multiple genotypes were circulating simultaneously in the Belgian community during 1 the study period. However, the subgroup A genotype GA5 and subgroup B genotype GB13, 2 which included strains with the 60-nt duplicated region (42), were isolated more frequently 3 during the study period and were identified to be the predominant HRSV genotype in 4 respectively 5 and 2 epidemic seasons. Interestingly, GB13 strains of different predicted G 5 protein lengths were prevailing during these two seasons. Previous investigations have 6 reported a replacement of the predominating HRSV genotype to occur each year (5, 11, 33) . 7
Conversely, we did not identify such annual shift of the prevailing genotype among 8 hospitalized patients in Belgium. GA5 remained the dominant HRSV genotype in two 9 subsequent epidemic seasons twice during the study period. This genotype was reported to be 10 predominant among HRSV-A strains during three consecutive seasons in a community in 11 Japan (35) and India (30), and was the most represented HRSV-A genotype in Sweden (34) 12 and New Zealand in recent years (24). Higher antigenic diversity among the GA5 strains is 13 most likely responsible for the ability of this genotype to persist and prevail more frequently 14 in certain communities (3, 30) . This study included only one hospital in Belgium and the 15 majority of patients were inhabitants of the Flemish part of Belgium. Nevertheless, taking into 16 account that Belgium is a small country with a dense population and that people commute 17 frequently for work to another city, we believe that our findings on HRSV subgroup and 18 genotype distribution patterns are likely to be representative for the whole country. Belgian community implies that this genotype is probably evolving under stronger selective 7 pressure in comparison to other HRSV-B genotypes. This is consistent with the increased 8 average substitution rate reported for HRSV-B viruses possessing the 60-nt duplication (43). 9
Another possible explanation for the more frequent occurrence of subgroup A is that 10 subgroup B may elicit a more complete and/or long-lasting subgroup-specific immune 11 response than subgroup A and therefore causes less often disease (18). In support of this 12 speculation, only one of the five HRSV homologous reinfections observed in this study was 13 caused by subgroup B viruses. This is in accordance with previous studies, in which also 14 more subgroup A than subgroup B homologous reinfections have been detected (25, 31, 35, 15 36). Most of the repeated infections observed in this study occurred in two subsequent 16 epidemic seasons and were caused by strains of different subgroups. In addition, we identified 17 nine patients that were coinfected with HRSV-A and -B viruses. Interestingly, one (amino 18 acid position 117) and three (amino acid positions 223, 247, and 258) of the amino acid 19 changes identified between the subgroup A and B strains that caused homologous infections, 20 respectively, were at positions that have been identified to be under positive selection pressure 21 (48, 49) . 22
In summary, a regular 3-year periodic cycle of HRSV subgroup occurrence was observed 23 among hospitalized patients in a community in Belgium during a period of 10 successive 24 epidemic seasons. This pattern consisted of two HRSV-A prevailing seasons, followed by asingle season of HRSV-B predominance. Multiple genotypes were cocirculating during each 1 epidemic and successful genotypes were predominating for more than one season. Higher 2 genetic and antigenic diversity among GA5 and GB13 strains is most likely responsible for 3 the ability of these genotypes to prevail for a prolonged period of time in the Belgian 4 community. We speculate that the observed overall prevalence of HRSV-A over HRSV-B 5 viruses could be due to a more transient subgroup A specific immune protection, rather a than 6 higher HRSV-A genetic diversity as has been previously suggested. 
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